Camber Pharma Launches Generic Sensipar®

Piscataway, NJ, December 10, 2020– Camber Pharmaceuticals is pleased to announce that it has launched Cinacalcet Tablets, which is the generic version of Sensipar®.
Cinacalcet Tablets are used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.
Cinacalcet Tablets are available from Camber in 30, 60 and 90mg- 30 count bottles.
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year